Suppr超能文献

儿童、青少年和青年成人在儿科机构接受儿科方案治疗后的造血干细胞移植后窦腔阻塞综合征的诊断和分级。

Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols.

机构信息

Allergy Immunology and BMT, University of California, San Francisco, California.

Allergy Immunology and BMT, University of California, San Francisco, California.

出版信息

Transplant Cell Ther. 2024 Jul;30(7):690.e1-690.e16. doi: 10.1016/j.jtct.2024.04.006. Epub 2024 Apr 16.

Abstract

Sinusoidal obstructive syndrome (SOS), or veno-occlusive disease, of the liver has been recognized as a complex, life-threatening complication in the posthematopoietic stem cell transplant (HSCT) setting. The diagnostic criteria for SOS have evolved over the last several decades with a greater understanding of the underlying pathophysiology, with 2 recent diagnostic criteria introduced in 2018 (European Society of Bone Marrow Transplant [EBMT] criteria) and 2020 (Cairo criteria). We sought out to evaluate the performance characteristics in diagnosing and grading SOS in pediatric patients of the 4 different diagnostic criteria (Baltimore, Modified Seattle, EBMT, and Cairo) and severity grading systems (defined by the EBMT and Cairo criteria). Retrospective chart review of children, adolescent, and young adults who underwent conditioned autologous and allogeneic HSCT between 2017 and 2021 at a single pediatric institution. A total of 250 consecutive patients underwent at least 1 HSCT at UCSF Benioff Children's Hospital San Francisco for a total of 307 HSCT. The day 100 cumulative incidence of SOS was 12.1%, 21.1%, 28.4%, and 28.4% per the Baltimore, Modified Seattle, EBMT, and Cairo criteria, respectively (P < .001). We found that patients diagnosed with grade ≥4 SOS per the Cairo criteria were more likely to be admitted to the Pediatric Intensive Care Unit (92% versus 58%, P = .035) and intubated (85% versus 32%, P = .002) than those diagnosed with grade ≥4 per EBMT criteria. Age <3 years-old (HR 1.76, 95% [1.04 to 2.98], P = .036), an abnormal body mass index (HR 1.69, 95% [1.06 to 2.68], P = .027), and high-risk patients per our institutional guidelines (HR 1.68, 95% [1.02 to 2.76], P = .041) were significantly associated with SOS per the Cairo criteria. We demonstrate that age <3 years, abnormal body mass index, and other high-risk criteria associate strongly with subsequent SOS development. Patients with moderate to severe SOS based on Cairo severity grading system may correlate better with clinical course based on ICU admissions and intubations when compared to the EBMT severity grading system.

摘要

窦状隙阻塞综合征(SOS),又称肝静脉阻塞病,是造血干细胞移植(HSCT)后一种复杂的、危及生命的并发症。随着对其潜在病理生理学认识的不断深入,SOS 的诊断标准在过去几十年中不断演变,目前有 2 种最新的诊断标准于 2018 年(欧洲骨髓移植学会 [EBMT] 标准)和 2020 年(开罗标准)引入。我们旨在评估这 4 种不同的诊断标准(巴尔的摩、改良西雅图、EBMT 和开罗)和严重程度分级系统(EBMT 和开罗标准定义)在诊断和分级儿科患者 SOS 方面的表现特征。回顾性分析了 2017 年至 2021 年在一家儿科单中心接受条件性自体和同种异体 HSCT 的儿童、青少年和年轻成人的病历。共有 250 例连续患者在旧金山加州大学旧金山分校贝尼奥夫儿童医院接受了至少 1 次 HSCT,共进行了 307 次 HSCT。根据巴尔的摩、改良西雅图、EBMT 和开罗标准,第 100 天 SOS 的累积发生率分别为 12.1%、21.1%、28.4%和 28.4%(P<0.001)。我们发现,根据开罗标准诊断为≥4 级 SOS 的患者更有可能被收入儿科重症监护病房(92%比 58%,P=0.035)和插管(85%比 32%,P=0.002),而根据 EBMT 标准诊断为≥4 级的患者则没有。年龄<3 岁(HR 1.76,95%[1.04 至 2.98],P=0.036)、体重指数异常(HR 1.69,95%[1.06 至 2.68],P=0.027)和我们机构指南中的高危患者(HR 1.68,95%[1.02 至 2.76],P=0.041)与开罗标准下的 SOS 显著相关。我们证明,年龄<3 岁、体重指数异常和其他高危标准与随后的 SOS 发展密切相关。与 EBMT 严重程度分级系统相比,根据开罗严重程度分级系统为中重度 SOS 的患者可能与 ICU 入院和插管等临床病程更相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验